Aktie RUBRAME6 CHECKPOINT TRENDS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Checkpoint Trends Limited

Aktien

RUBRAME6

INE396H01019

RUBRAME6

Verzögert Bombay S.E.
Andere Börsenplätze
 12:00:55 26.06.2024 		% 5 Tage % 1. Jan.
9,19 INR -0,97 % Intraday Chart für Checkpoint Trends Limited -2,96 % +98,06 %
25.05. Checkpoint Trends Limited gibt das Ausscheiden von Sunil Khandalwal als Managing Director mit Wirkung vom 27. Mai 2024 bekannt CI
25.05. Checkpoint Trends Limited meldet die Ergebnisse für das vierte Quartal und das Gesamtjahr zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Checkpoint Trends Limited Announces Cessation of Sunil Khandalwal as Managing Director, with Effect from May 27, 2024
Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Checkpoint Trends Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Checkpoint Trends Limited Announces Resignation of Komal Behl, Company Secretary
Checkpoint Trends Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Checkpoint Trends Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Checkpoint Trends Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Checkpoint Trends Limited Announces Company Secretary Changes
Checkpoint Trends Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Rubra Medicaments Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Rubra Medicaments Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Rubra Medicaments Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Rubra Medicaments Gets Board Approval to Change Name
Rubra Medicaments Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Rubra Medicaments' Net Profit Soars in Fiscal Q2
Rubra Medicaments Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Rubra Medicaments Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
Rubra Medicaments Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021
Rubra Medicaments Limited Appoints Harish Surve as Independent Director
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. RUBRAME6 Aktie
  4. Nachrichten Checkpoint Trends Limited
  5. Andere Sprachen